RT Journal Article
SR Electronic
T1 Risk factors for SARS-CoV-2 infection among farmworkers in Monterey County, California
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.01.21250963
DO 10.1101/2021.02.01.21250963
A1 Ana M. Mora
A1 Joseph A. Lewnard
A1 Katherine Kogut
A1 Stephen A. Rauch
A1 Norma Morga
A1 Samantha Hernandez
A1 Marcus P. Wong
A1 Karen Huen
A1 Cynthia Chang
A1 Nicholas P. Jewell
A1 Nina Holland
A1 Eva Harris
A1 Maximiliano Cuevas
A1 Brenda Eskenazi
A1 on behalf of the CHAMACOS-Project-19 Study Team
YR 2021
UL http://medrxiv.org/content/early/2021/02/03/2021.02.01.21250963.abstract
AB Importance Essential workers in agriculture and food production have been severely affected by the ongoing COVID-19 pandemic.Objective To identify risk factors associated with SARS-CoV-2 shedding and antibody response in farmworkers in California.Design This cross-sectional study collected survey data and determined current SARS-CoV-2 shedding and seropositivity among 1,107 farmworkers in California’s Salinas Valley from 16 July to 30 November 2020.Setting Farmworkers receiving transcription-mediated amplification (TMA) tests for SARS-CoV-2 infection at federally qualified community clinics and community sites were invited to participate in our study.Participants Individuals were eligible if they were not pregnant, ≥18 years old, had conducted farm work since the pandemic started, and were proficient in English or Spanish.Exposures Sociodemographic, household, community, and workplace characteristics.Main Outcome(s) and Measure(s) Current (as indicated by TMA positivity) and historical (as indicated by IgG seropositivity) SARS-CoV-2 infection.Results Most farmworkers enrolled in the study were born in Mexico, had primary school or lower levels of educational attainment, and were overweight or obese. Current SARS-CoV-2 shedding was associated in multivariable analyses with attained only primary or lower educational levels (RR=1.32; 95% CI: 0.99-1.76), speaking an indigenous language at home (RR=1.30; 0.97-1.73), working in the fields (RR=1.60; 1.03-2.50), and exposure to known or suspected COVID-19 case at home (RR=2.98; 2.06-4.32) or in the workplace (RR=1.59; 1.18-2.14). Antibody detection was associated with residential exposures including living in crowded housing (RR=1.23; 0.98-1.53), with children (RR=1.40; 1.1-1.76) or unrelated roommates (RR=1.40; 1.19-1.64), and with a known or suspected COVID-19 case (RR=1.59; 1.13-2.24). Those who were obese (RR=1.65; 1.01-2.70) or diabetic (RR=1.31; 0.98-1.75) were also more likely to be seropositive. Farmworkers who lived in rural areas other than Greenfield (RR=0.58; 0.47-0.71), worked indoors (RR=0.68; 0.61-0.77), or whose employer provided them with information on how to protect themselves at work (RR=0.59; 0.40-0.86) had lower risk of prior infection.Conclusions and Relevance Our findings suggest both residential and workplace exposures are contributing to SARS-CoV-2 infection among farmworkers in California. Urgent distribution of COVID-19 vaccines is warranted given this population’s increased risk of infection and the essential nature of their work.Competing Interest StatementJAL has received grants and consulting fees from Pfizer, Inc. unrelated to this research. All other authors declare no conflicts of interest.Funding StatementThis work was supported by the Innovative Genomics Institute and Clinica de Salud del Valle de Salinas.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was obtained from the Institutional Review Board at the University of California, Berkeley (Protocol Number: 2020-06-13404).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDirect data requests to the corresponding author at animora@berkeley.edu.